Ardent Health Partners (NYSE:ARDT) Given “Overweight” Rating at Stephens

Stephens restated their overweight rating on shares of Ardent Health Partners (NYSE:ARDT) in a research report released on Wednesday morning,Benzinga reports. The firm currently has a $22.00 target price on the stock.

ARDT has been the subject of several other research reports. Royal Bank of Canada decreased their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a research report on Tuesday, March 4th. Morgan Stanley decreased their target price on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. Truist Financial lowered their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $20.00 price target on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Ardent Health Partners currently has a consensus rating of “Buy” and a consensus price target of $21.18.

Ardent Health Partners Trading Up 0.1 %

Shares of NYSE ARDT opened at $13.18 on Wednesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners has a 52-week low of $12.87 and a 52-week high of $20.72. The business’s 50 day moving average is $14.41 and its two-hundred day moving average is $16.25.

Ardent Health Partners (NYSE:ARDT) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.48 billion. As a group, equities research analysts predict that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Point72 Asia Singapore Pte. Ltd. acquired a new position in Ardent Health Partners in the fourth quarter valued at approximately $27,000. US Bancorp DE purchased a new stake in shares of Ardent Health Partners during the 4th quarter worth approximately $31,000. R Squared Ltd acquired a new position in shares of Ardent Health Partners in the 4th quarter valued at $37,000. BNP Paribas Financial Markets acquired a new position in shares of Ardent Health Partners in the 3rd quarter valued at $42,000. Finally, New York State Common Retirement Fund purchased a new position in shares of Ardent Health Partners in the 4th quarter valued at $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.